Neogen Corporation Faces Securities Class Action Lawsuit
Neogen Corporation is currently embroiled in a class action lawsuit that has significant implications for its shareholders. Investors who purchased Neogen's stock between January 5, 2023, and June 3, 2025, may find themselves affected by the ongoing legal proceedings. This lawsuit is in response to allegations that the company failed to disclose crucial details about its financial health during the class period, thereby violating federal securities laws.
Understanding the Class Action Lawsuit
The key issue in this legal matter is that certain executives at Neogen allegedly missed disclosing essential information that could impact stock prices. In a pivotal disclosure on April 9, 2025, Neogen reported a quarterly revenue drop of 3.4%, admitting to integration issues. Additionally, the company revised its fiscal guidance for the year, which included a concerning prediction of $100 million in capital expenditures tied to diminished adjusted EBITDA.
The drastic announcement led to a significant decline in Neogen's share price, with it falling approximately 28% to close at $5.02 per share. Following this, another adverse report on June 4, 2025, regarding the company's expected EBITDA margin further impacted its stock valuation, leading to another 17% drop, closing at $4.96 per share.
What Investors Can Do
For those who believe they are impacted by these developments, it is crucial to act promptly. Investors may still file lead plaintiff applications to participate in the class action lawsuit. The deadline for filing is September 16, 2025. Those interested in pursuing this path should consult with legal experts to understand their rights and options.
Contacting Legal Experts
Potential plaintiffs are encouraged to reach out to legal firms that specialize in securities litigation, such as Kahn Swick & Foti, LLC. They offer consultations without any obligation, allowing investors to learn about their rights and any potential for recovery for economic losses. A toll-free number available for inquiries is 1-877-515-1850.
About Neogen Corporation
Neogen Corporation is a prominent player in the health and safety sector, focusing on food safety, animal safety, and veterinary diagnostics. The company develops and markets a range of products to ensure food safety and enhance animal health. Recent challenges have drawn attention to their operational competencies, and how corporate governance practices can prevent such issues in the future.
Importance of Corporate Governance
The ongoing lawsuit sheds light on the critical role of transparency and proper communication in corporate governance. Stakeholders rely on accurate and timely information to make informed decisions in the stock market. Neogen's situation acts as a reminder to all publicly traded companies about the necessity of maintaining clear and honest communication with their investors to mitigate risks of legal liabilities.
Frequently Asked Questions
What is the class action lawsuit against Neogen Corporation about?
The lawsuit involves allegations that Neogen failed to disclose key financial information, leading to significant stock price drops during the class period.
When is the deadline for filing lead plaintiff applications?
The deadline for filing applications is September 16, 2025, for investors who purchased shares during the specified class period.
Who can join the lawsuit?
Any investor who bought Neogen Corporation shares between January 5, 2023, and June 3, 2025, may be eligible to participate in the class action.
How can I contact legal experts regarding my rights?
Investors can contact Kahn Swick & Foti at their toll-free number 1-877-515-1850 for consultations about their options related to the lawsuit.
What are the consequences of this lawsuit for Neogen Corporation?
Depending on the lawsuit's outcome, Neogen Corporation may face financial liabilities and a damaged reputation, impacting shareholder trust and future operations.
